Mangiferin, a C-glucosyl xanthone from mango fruit, has traditionally been studied as an antioxidant. Whether this natural compound promotes poststroke neural repair remains unknown. Using a genetically engineered high-throughput screen, we identified mangiferin as one of the most potent inducers of nerve growth factor (NGF) expression among the screened natural compounds. Mangiferin enhanced tropomyosin receptor kinase A (TrkA) phosphorylation and downstream extracellular signal-regulated kinase/cAMP response element-binding protein (ERK/CREB) signaling, accompanied by increased neural stem cell proliferation, neuronal and astrocytic differentiation, and protection against ischemic injury. These effects were attenuated by TrkA inhibition, supporting TrkA-dependent signaling. In a rat model of ischemic stroke, mangiferin reduced cerebral infarct volume, improved neurobehavioral outcomes, and increased cellular and histological markers associated with endogenous neural repair in the peri-infarct region. These findings identify mangiferin as a TrkA-targeting natural compound with neuroprotective and neurorestorative potential for poststroke neural repair.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: